- $2.26bn
- $8.86bn
- $60.86bn
- 61
- 92
- 89
- 94
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 32,897 | 54,140 | 42,534 | 66,036 | 60,856 |
Cost of Revenue | |||||
Gross Profit | 951 | 1,204 | 1,582 | 1,927 | 2,054 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 32,786 | 53,933 | 42,380 | 65,759 | 60,533 |
Operating Profit | 111 | 207 | 154 | 277 | 323 |
Net Income Before Taxes | 111 | 207 | 154 | 277 | 323 |
Provision for Income Taxes | |||||
Net Income After Taxes | 85.1 | 170 | 116 | 207 | 239 |
Net Income Before Extraordinary Items | |||||
Net Income | 85.1 | 170 | 116 | 207 | 239 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 83.6 | 166 | 113 | 201 | 230 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.93 | 3.42 | 3.93 | 6.58 | 7.2 |